Roche Holding AG (RHHBY)
50.23
-0.32
(-0.63%)
USD |
OTCM |
Jun 09, 16:00
Roche 1 Year Total Returns (Daily) : 26.76% for June 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 09, 2026 | 26.76% |
| June 08, 2026 | 27.54% |
| June 05, 2026 | 30.20% |
| June 04, 2026 | 30.30% |
| June 03, 2026 | 26.35% |
| June 02, 2026 | 24.35% |
| June 01, 2026 | 28.47% |
| May 29, 2026 | 36.67% |
| May 28, 2026 | 37.46% |
| May 27, 2026 | 36.91% |
| May 26, 2026 | 36.69% |
| May 22, 2026 | 40.71% |
| May 21, 2026 | 37.95% |
| May 20, 2026 | 34.84% |
| May 19, 2026 | 36.14% |
| May 18, 2026 | 34.97% |
| May 15, 2026 | 37.16% |
| May 14, 2026 | 41.60% |
| May 13, 2026 | 37.83% |
| May 12, 2026 | 34.08% |
| May 11, 2026 | 38.13% |
| May 08, 2026 | 34.67% |
| May 07, 2026 | 29.31% |
| May 06, 2026 | 30.78% |
| May 05, 2026 | 26.81% |
| Date | Value |
|---|---|
| May 04, 2026 | 26.18% |
| May 01, 2026 | 32.84% |
| April 30, 2026 | 28.66% |
| April 29, 2026 | 27.86% |
| April 28, 2026 | 29.89% |
| April 27, 2026 | 33.61% |
| April 24, 2026 | 33.93% |
| April 23, 2026 | 36.60% |
| April 22, 2026 | 35.41% |
| April 21, 2026 | 32.66% |
| April 20, 2026 | 36.03% |
| April 17, 2026 | 35.87% |
| April 16, 2026 | 33.42% |
| April 15, 2026 | 36.54% |
| April 14, 2026 | 37.46% |
| April 13, 2026 | 37.16% |
| April 10, 2026 | 39.95% |
| April 09, 2026 | 39.80% |
| April 08, 2026 | 43.81% |
| April 07, 2026 | 41.32% |
| April 06, 2026 | 36.85% |
| April 02, 2026 | 30.53% |
| April 01, 2026 | 26.48% |
| March 31, 2026 | 24.54% |
| March 30, 2026 | 20.11% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Novartis AG | 30.20% |
| Eli Lilly & Co. | 48.98% |
| Pfizer Inc. | 14.75% |
| GSK Plc | 30.20% |
| Johnson & Johnson | 56.49% |